Charles Schwab Investment Management Inc Biomea Fusion, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 116,549 shares of BMEA stock, worth $186,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,549

Previous 181,380 35.74%

Holding current value

$186,478

Previous $386,000 45.85%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$1.37 - $2.9 $88,818 - $188,009	-64,831 Reduced 35.74%	116,549 $209,000
Q1 2025 Sep 15, 2025	BUY	$2.13 - $4.48 $138,090 - $290,442	64,831 Added 55.63%	181,380 $386,000
Q1 2025 May 09, 2025	SELL	$2.13 - $4.48 $40,448 - $85,075	-18,990 Reduced 9.48%	181,380 $386,000
Q4 2024 Feb 06, 2025	SELL	$3.88 - $12.41 $31,121 - $99,540	-8,021 Reduced 3.85%	200,370 $777,000
Q3 2024 Nov 12, 2024	BUY	$4.23 - $10.1 $31,940 - $76,265	7,551 Added 3.76%	208,391 $2.1 Million
Q2 2024 Aug 12, 2024	BUY	$4.14 - $15.3 $90,686 - $335,146	21,905 Added 12.24%	200,840 $903,000
Q1 2024 May 08, 2024	BUY	$13.92 - $19.5 $29,760 - $41,691	2,138 Added 1.21%	178,935 $2.68 Million
Q4 2023 Feb 06, 2024	BUY	$8.37 - $19.8 $19,828 - $46,906	2,369 Added 1.36%	176,797 $2.57 Million
Q3 2023 Nov 08, 2023	BUY	$13.44 - $23.02 $1.6 Million - $2.74 Million	119,001 Added 214.7%	174,428 $2.4 Million
Q2 2023 Aug 09, 2023	BUY	$21.66 - $41.8 $1.03 Million - $2 Million	47,747 Added 621.71%	55,427 $1.22 Million
Q1 2023 May 11, 2023	BUY	$6.8 - $32.35 $52,224 - $248,448	7,680 New	7,680 $238,000
Q2 2022 Aug 15, 2022	SELL	$3.0 - $12.03 $159,840 - $640,958	-53,280 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.39 - $9.03 $11,725 - $24,119	2,671 Added 5.28%	53,280 $238,000
Q4 2021 Feb 11, 2022	BUY	$7.22 - $12.72 $206,990 - $364,669	28,669 Added 130.67%	50,609 $378,000
Q2 2021 Aug 16, 2021	BUY	$13.65 - $20.93 $299,481 - $459,204	21,940 New	21,940 $343,000

Others Institutions Holding BMEA

# of Institutions

Shares Held

23.1M

Call Options Held

1.08M

Put Options Held

359K

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $46.9M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Biomea Fusion, Inc. Transaction History